NASDAQ:CODX Co-Diagnostics Q3 2026 Earnings Date & Estimates $0.26 -0.01 (-3.86%) Closing price 11/6/2026 04:00 PM EasternExtended Trading$0.27 +0.02 (+5.92%) As of 11/6/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Co-Diagnostics is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 10, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Co-Diagnostics in Q3 2026Co-Diagnostics is expected to post earnings of -$1.25 per share on revenue of $169 thousand. In the same quarter a year earlier Co-Diagnostics reported -$4.80 per share on revenue of $145.38 thousand. Co-Diagnostics last reported on August 13, 2026, posting -$1.46 per share and beating the -$3.00 consensus estimate. Co-Diagnostics has beaten the consensus EPS estimate in 5 of its last 8 quarters.Consensus EstimatesConsensus EPS-$1.25Expected Revenue$169 thousandPrior-Year EPS-$4.80Prior-Year Revenue$145.38 thousandExpected Revenue Growth+16.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$1.46 (Beat by +$1.54)Last Quarter Revenue$166.13 thousandEPS Beat Rate5 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Co-Diagnostics Q3 2026 Earnings FAQ When does Co-Diagnostics report Q3 2026 earnings? Co-Diagnostics (NASDAQ:CODX) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Co-Diagnostics' Q3 2026 earnings call? Co-Diagnostics' Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Co-Diagnostics? Analysts expect Co-Diagnostics to post earnings of -$1.25 per share for Q3 2026. How much revenue is Co-Diagnostics expected to report? The consensus revenue estimate for Co-Diagnostics is $169 thousand for Q3 2026. Co-Diagnostics Earnings HeadlinesCo-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and WebcastNovember 5 at 5:00 PM | prnewswire.comCo-Diagnostics to Participate in Three Global Tuberculosis Events in November as CoSara Advances Toward Anticipated India LaunchNovember 5 at 9:00 AM | prnewswire.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 8 at 1:00 AM | Behind the Markets (Ad)Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and WebcastOctober 29, 2026 | prnewswire.comCo-Diagnostics' Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara's SARAGENE® TestOctober 29, 2026 | prnewswire.comCo-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in IndiaOctober 27, 2026 | prnewswire.comSee More Co-Diagnostics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Co-Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Co-Diagnostics and other key companies, straight to your email. Email Address About Co-DiagnosticsCo-Diagnostics (NASDAQ:CODX) is a molecular diagnostics company that develops and commercializes diagnostic tests and laboratory technologies. Based in Salt Lake City, Utah, the company focuses on assays that detect genetic material from infectious diseases and other medical conditions. The company’s core technology is its CoPrimer platform, which is designed to support the development of molecular tests using specialized primer technology. Products associated with the platform include the Logix Smart line of real-time polymerase chain reaction (PCR) assays, covering applications such as respiratory and other infectious diseases. Co-Diagnostics has also developed tests for conditions including tuberculosis and mosquito-borne diseases, with product availability and regulatory status varying by jurisdiction. Founded in 2013, Co-Diagnostics serves clinical laboratories, healthcare providers, and distribution partners in the United States and international markets. Its tests and systems may be offered for research, laboratory, or diagnostic use depending on applicable regulatory approvals, and the company continues to expand its molecular testing portfolio through internal development and commercialization partnerships.View Co-Diagnostics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 11/2 - 11/6IonQ's Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?Sandisk Shares Are Oversold: Bargain or Value Trap?Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal? Upcoming Earnings Occidental Petroleum (11/9/2026)KKR & Co. Inc. (11/9/2026)Barrick Mining (11/9/2026)Constellation Energy (11/9/2026)Petroleo Brasileiro S.A.- Petrobras (11/10/2026)Transdigm Group (11/10/2026)Honda Motor (11/11/2026)Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
